Olumiant Expected to Shorten Time to Recovery from COVID-19: Infection Expert

Sho Saito, National Center for Global Health and Medicine Eli Lilly’s JAK inhibitor Olumiant (baricitinib), which has recently been approved for an additional indication of COVID-19 pneumonia in Japan, is expected to shorten the patient recovery time in combination with...read more